Detalhe da pesquisa
1.
CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency.
Cancer Sci
; 108(3): 469-477, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004478